Tuesday May 15 2018

/Sessions/Tuesday May 15 2018

Opening Session

09:30-09:50 Welcome by Conference Chairperons: Ruti Alon, Founder and CEO, Medstrada Ora Dar, PhD, Israel Innovation Authority Nissim Darvish, MD, PhD, Senior Managing Director, OrbiMed 09:50-10:35 Arie S. Belldegrun MD, FACS, Founder, Kite Pharma; Executive Chairman & Co-Founder, Allogene Therapeutics: “Passing the Torch” 10:35-11:20 Francois Maisonrouge, Senior Managing Director, Evercore Partners:  "Health Care in 2020: Will we still Pay for Innovation?"

By | 2018-04-30T13:34:15+00:00 February 19th, 2018|Comments Off on Opening Session

Novel Clinical Trial Designs and Technologies to Accelerate Drug Development

Chair: Iris Grossman, PhD, Chief Scientific Officer, Camp4 Therapeutics 11:50-12:00 Iris Grossman, PhD, Chief Scientific Officer, Camp4 Therapeutics: “Introduction” 12:00-12:20 Iris Grossman, PhD, Chief Scientific Officer, Camp4 Therapeutics: "Regulatory Landscape, from Cures Act to INFORMED, Recent Guidances and Future Perspective" 12:20-12:35 Erhan Bilal, PhD, IBM Research, Computational Biology Center: "Sensor-based Assessment of Parkinson's Disease" 12:35-12:50 Marc Funk, [...]

By | 2018-05-13T11:19:36+00:00 February 19th, 2018|Comments Off on Novel Clinical Trial Designs and Technologies to Accelerate Drug Development

Fighting Rare Genetic Diseases Using Novel Therapeutic Approaches

Chair: Yael Weiss, MD, PhD, Vice President Business Development, Ultragenyx 11:50-12:00 Yael Weiss, MD, PhD, Vice President Business Development, Ultragenyx: “Opening Remarks” 12:00-12:15 Julia Hawkins, Partner, LocalGlobe: "The Journey of a Parent to a Child with a Rare Genetic Condition" 12:15-12:35 Tal Zaks, MD, PhD, Chief Medical Officer Moderna Therapeutics: "Moderna mRNA Therapies for Rare Genetic Diseases" [...]

By | 2018-05-10T13:58:29+00:00 February 19th, 2018|Comments Off on Fighting Rare Genetic Diseases Using Novel Therapeutic Approaches


Next Generation Oncology Treatments

Chair: Prof. David Sidransky, MD, Johns Hopkins School of Medicine and Israel Biotech Fund, Co-Founder and General Partner Immune Oncology 11:50-11:55 Prof. David Sidransky, MD, Johns Hopkins School of Medicine and Israel Biotech Fund, Co-Founder and General Partner 11:55-12:35 Prof. Jeffrey A. Sosman, MD, Director, Melanoma Program, Director, Faculty Development, Co-Leader, Translational Research in Solid [...]

By | 2018-05-10T13:57:15+00:00 February 19th, 2018|Comments Off on
Next Generation Oncology Treatments